Startseite>>Signaling Pathways>> Others>>Tiafenacil

Tiafenacil

Katalog-Nr.GC63227

Tiafenacil ist ein neues Protoporphyrinogen-IX-Oxidase (PPO)-hemmendes Herbizid mit IC50-Werten von 22 bis 28 nM fÜr verschiedene Pflanzenarten, darunter Amaranth (Amaranthus tuberculatus), Sojabohne (Glycine max), Arabidopsis (Arabidopsis thaliana) und Raps (Brassica napus).

Products are for research use only. Not for human use. We do not sell to patients.

Tiafenacil Chemische Struktur

Cas No.: 1220411-29-9

Größe Preis Lagerbestand Menge
10mM (in 1mL DMSO)
658,80 $
Auf Lager
5 mg
585,00 $
Auf Lager
10 mg
1.035,00 $
Auf Lager
25 mg
2.205,00 $
Auf Lager
50 mg
3.465,00 $
Auf Lager
100 mg
5.265,00 $
Auf Lager

Tel:(909) 407-4943 Email: sales@glpbio.com


Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Tiafenacil is a new protoporphyrinogen IX oxidase (PPO)-inhibiting herbicide, with IC50 values of 22 to 28 nM for various plant species, including amaranth (Amaranthus tuberculatus), soybean (Glycine max), arabidopsis (Arabidopsis thaliana), and rapeseed (Brassica napus)[1].

Tiafenacil has low oral and dermal acute toxicity[1].In velvetleaf, Tiafenacil causes severe growth inhibition at 1 µM and results in desiccation and death at 5 µM[1].

[1]. Joonghyuk Park, et al. Biochemical and physiological mode of action of tiafenacil, a new protoporphyrinogen IX oxidase-inhibiting herbicide. Pestic Biochem Physiol. 2018 Nov;152:38-44.

Bewertungen

Review for Tiafenacil

Average Rating: 5 ★★★★★ (Based on Reviews and 36 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Tiafenacil

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.